Jonathan Biller's Net Worth
$11.9 Million
Who is Jonathan Biller?
Jonathan Biller has an estimated net worth of $11.9 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS, INC., CELGENE CORP /DE/, and VERTEX PHARMACEUTICALS INC / MA.
SEC CIK
Jonathan Biller's CIK is 0001744749
Past Insider Trading and Trends
2019 was Jonathan Biller's most active year for acquiring shares with 6 total transactions. Jonathan Biller's most active month to acquire stocks was the month of January. 2019 was Jonathan Biller's most active year for disposing of shares, totalling 33 transactions. Jonathan Biller's most active month to dispose stocks was the month of October. 2019 saw Jonathan Biller paying a total of $0.00 for 152,872 shares, this is the most they've acquired in one year. In 2024 Jonathan Biller cashed out on 3,326 shares for a total of $1,399,133.38, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +34.09% | 5.83K |
$29.08 | -$78,167.04 | 22.95K |
Feb 18 - Feb 22
| |||
Form 4
| +15.66% | 2.32K |
$31.43 | -$42,392.32 | 17.12K |
Feb 10
| |||
Form 4
| +36.15% | 3.93K |
$35.88 | -$65,405.78 | 14.8K |
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
| +67.50% | 4.05K |
$45.87 | -$78,300.09 | 10.04K |
Dec 3
| |||
Form 4
|
∞
| 5.99K |
$40.64 | -$102,778.56 | 5.99K |
Apr 13 - Apr 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CELGENE CORP /DE/ No price found
EVP AND GENERAL COUNSEL
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 20
| |||
Form 4
| -100.00% | -7.14K |
—
|
—
|
0
|
Nov 20
| |||
Form 4
| +49.74% | 2.08K |
$108.03 | -$112,783.32 | 6.26K |
Oct 31
| |||
Form 4
| +34.49% | 1.07K |
$95.21 | -$46,652.90 | 4.18K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| +44.97% | 965 |
$68.20 | -$63,767.00 | 3.11K |
Dec 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VERTEX PHARMACEUTICALS INC / MA (VRTX) Snapshot price: $468
EVP and Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.39% | -3.33K |
$420.67 | -$1,399,133.38 | 18.28K |
Scheduled
|
Feb 9 - Feb 12
| ||
Form 4
| +104.43% | 11.04K |
—
|
—
| 21.61K |
Feb 6 - Feb 7
| |||
Form 4
| -8.79% | -1.02K |
$348.35 | -$354,617.36 | 10.57K |
Sep 29 - Oct 2
| |||
Form 4
| +118.87% | 6.29K |
—
|
—
| 11.59K |
Feb 1
| |||
Form 4
|
∞
| 5.29K |
—
|
—
| 5.29K |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||